The cost of drug development has drastically increased to >$1 billion contributing to a decline in the productivity of the pharmaceutical industry. This opens up opportunities for biotech companies like iCellVivo, Inc. to develop next-generation interacting multiple human organ test systems for drug discovery, toxicity testing and 3d stem cell assays potentially reducing the need for animal testing. iCellVivo, Inc. is developing a 6-well based multiorgan platform with integrated electrophysiological assay to improve clinical predictability and reduce animal testing. This patent pending portable, open-well configuration multiorgan platform uses microfluidic plate and 3-D inserts for standard well-plates to perform preclinical toxicity profiling.
Company Details
- Founded
- -
- Address
- 4100 E Peltason Dr, Irvine,california 92617,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Irvine, California
- Competitors
- 28bio, Biopico Systems INC, Okomera.
Icellvivo Questions
Icellvivo's website is http://www.linkedin.com/in/iCellVivo
Icellvivo's LinkedIn profile is https://www.linkedin.com/company/icellvivo
Icellvivo's industry is
Biotechnology Research
Icellvivo's categories are Biotechnology Research
Icellvivo's founding year is 2017
